Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Rheumatology|August 24, 2000
Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placeboW G Bensen, S Z Zhao, T A Burke, et al.
The Journal of Rheumatology|October 1, 1994
Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone lossJ Adachi, A Cranney, C H Goldsmith, et al.
Thrombosis and Haemostasis|November 1, 1991
The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional studyA A Long, J S Ginsberg, P Brill-Edwards, et al.
British Journal of Obstetrics and Gynaecology|January 1, 1997
A double-blind randomised controlled trial of the effects of medroxyprogesterone acetate on bone density of women taking oestrogen replacement therapyJ D Adachi, E J Sargeant, M A Sagle, et al.
Lancet (London, England)|May 5, 1990
Low-dose cyclosporin versus placebo in patients with rheumatoid arthritisP Tugwell, C Bombardier, M Gent, et al.
The Journal of Rheumatology|May 1, 1995
A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritisN Bellamy, W G Bensen, A Beaulieu, et al.
Arthritis and Rheumatism|February 28, 2009
Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled studyX Chevalier, P Goupille, A D Beaulieu, et al.
The Journal of Rheumatology|June 1, 1996
Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followupJ D Adachi, W G Bensen, F Bianchi, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1996
Intermittent cyclic therapy with etidronate prevents corticosteroid-induced bone loss: two years of follow-upR J Sebaldt, J D Adachi, W G Bensen, et al.
Rheumatology (Oxford, England)|March 12, 2004
Safety of tacrolimus in patients with rheumatoid arthritis: long-term experienceD E Yocum, D E Furst, W G Bensen, et al.
Pageof 4